Magazine issue

July/August 2024

July/August 2024

As the front cover so boldly suggests, this edition of PharmaTimes is at the ballot box! Indeed, we are pondering a future seems oddly elusive in spite of its alarming proximity! This is a very good reason for us to discuss the great themes of our time – who will take a country out of the debris of the last decade, what will become of our decrepit NHS, can we ever become best friends with AI, how can we ignite diversity throughout industry and, of course, how we can we make patient involvement vibe part of everyday pharma?

June 2024

June 2024

This issue is about the shaping, delivery and future of clinical trials – the exciting dawn of a new era for how therapies reach the marketplace. We cover the influence of digital, the radical shift in trial design and, above all, the need to incorporate patients at every stage. We’ve also got a review of our International Clinical Researcher of the Year bash – an unforgettable 25th edition of the enduring event. In addition, this issue looks at the influence of Florence Nightingale as an ace healthcare communicator, the future of unlicenced meds and the emerging involvement of AI across the life sciences.

May 2024

May 2024

This month we’re going places and – as our cover so boldly suggests – those places invite parity and equity. Women in pharma is a movement which not only yields a fair and more interesting pharmaverse, it ignites possibilities and propels performance. The edition of PharmaTimes you are about to peruse holds this reality aloft and parades it around our industry. We’ve also got a host of other features which demonstrate the rapid evolution of the life sciences including – the future of pharma, emerging novel therapies, taking on rare diseases and the continuing need to ensure a career in pharma is open to everyone.

April 2024

April 2024

Hope springs in this edition of PharmaTimes! By looking robots directly in the eye, we demystify how AI is influencing pharma and wider healthcare – as a force for good. Meanwhile, intrepid community pharmacists step out of the shadows and into bolder new arenas, helping to unshackle the NHS in the process. There are also captivating features on realising net-zero, campaign launches, men’s health and the evolving digital age. In addition, we continue to celebrate how new perspectives from women are igniting our industry and blazing a trail for the next generation. Yep, we’re living our best lives…

March 2024

March 2024

Land of the giants The genie is out of the bottle, folks – and we can’t put it back in. When Elon Musk’s people...

January/February 2024

January/February 2024

I’m a believer According to an agreed principle, set in stone (quite literally) over 2000 years ago, I believe it is...

December 2023

December 2023

Peace out When Bob Marley sang about ‘so much trouble in the world’ I’m fairly certain not even he could have...

November 2023

November 2023

Familiar foeAs winter looms, so too does a name that sends chills through our collective soul – COVID-19. The...

October 2023

October 2023

Screen timeAt the birth of cinema, over 125 years ago, folk flocked to theatres, intrigued by rumours of photographs...

September 2023

September 2023

The young onesFor centuries when people pondered about what the life sciences represented, ‘yoof culture’ would not...

July/August 2023

July/August 2023

The have botsLike an ever-lengthening shadow or – perhaps – an increasing level of enlightenment, AI is here!Our job,...

June 2023

June 2023

Partly like it’s 1747!I stress ‘partly’. Today’s clinical trials are evolving apace – perhaps more in the last four...

May 2023

May 2023

Listen without prejudiceThe title of George Michael’s seminal album, Listen Without Prejudice, imagined a world in...

April 2023

April 2023

Disturbing – but in a good wayDisruption! After doing many things the same way for a zillion years, healthcare systems...

March 2023

March 2023

Change seems to be the hardest wordMythologising about the NHS has fnally had its day of reckoning. And, alas, we’re...